GIC Sub-Industry 'Pharmaceuticals': 100 results
| Symbol | Industry | Market Cap | Fund. Score | Div. Score | Tech. Score | P/E | 12m vs SPY |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly |
Pharmaceuticals
Insulin, Diabetes, Oncology |
973B | 82.0% | 76.9% | 56.0% | 53.2 | 11.2% |
| JNJ Johnson & Johnson |
Pharmaceuticals
Pharmaceuticals, Devices, Lenses |
496B | 74.6% | 67.8% | 62.3% | 19.9 | 20.7% |
| ZEG AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
295B | 86.5% | 52.1% | 50.8% | 31.7 | 7.27% |
| AZN AstraZeneca |
Pharmaceuticals
Oncology, Cardiovascular |
291B | 79.6% | 47.5% | 60.9% | 31.2 | 21.7% |
| MRK Merck |
Pharmaceuticals
Oncology Vaccines Antimicrobials |
277B | 82.9% | 69.7% | 44.8% | 14.7 | -5.97% |
| NVS Novartis |
Pharmaceuticals
Cardiovascular, Oncology |
271B | 91.7% | 62.6% | 74.3% | 19.4 | 22.3% |
| NVO Novo Nordisk |
Pharmaceuticals
Insulin, Obesity, Growth, Blood |
255B | 89.2% | 45.1% | -31.5% | 15.7 | -40.9% |
| PFE Pfizer |
Pharmaceuticals
Medicines, Vaccines, Biosimilars |
144B | 57.8% | 79.0% | -4.43% | 14.7 | -15.6% |
| SNY Sanofi |
Pharmaceuticals
Vaccines, Immunology, Oncology |
117B | 61.8% | 59.6% | 9.01% | 15.8 | -12.8% |
| SAN Sanofi |
Pharmaceuticals
Vaccines, Oncology, Neurology |
116B | 75.3% | 69.3% | -21.6% | 15.7 | -23.2% |
| BMY Bristol-Myers |
Pharmaceuticals
Oncology, Immunotherapy |
114B | 73.4% | 84.4% | -1.37% | 18.8 | -12.2% |
| GSK GlaxoSmithKline |
Pharmaceuticals
Vaccines, Specialty Medicines |
101B | 76.9% | 26.3% | 80.6% | 14.0 | 33.1% |
| GS71 GSK |
Pharmaceuticals
Vaccines, Specialty Medicines |
98.1B | 80.1% | 37.1% | 55.6% | 13.7 | 17.7% |
| MRK Merck KGaA |
Pharmaceuticals
Reagents, Filtration, Antibodies |
64.6B | 61.5% | 66.0% | -14.3% | 18.8 | -23.1% |
| ZTS Zoetis |
Pharmaceuticals
Vaccines, Parasiticides |
55.7B | 83.4% | 73.3% | -50.9% | 21.8 | -35.9% |
| TAK Takeda |
Pharmaceuticals
Oncology, Gastroenterology |
52.0B | 60.5% | 38.1% | 55.8% | 223 | 8.74% |
| BAYN Bayer NA |
Pharmaceuticals
Pharmaceuticals, Consumer Health |
45.2B | 46.1% | 2.19% | 37.7% | - | 61.4% |
| TEVA Teva Pharma |
Pharmaceuticals
Generics, Respiratory, CNS |
37.3B | 53.0% | 17.4% | 68.2% | 53.3 | 29.7% |
| RPRX Royalty Pharma |
Pharmaceuticals
Royalties, Biopharma, Investments |
23.4B | 56.3% | 61.1% | 75.5% | 23.0 | 13.7% |
| VTRS Viatris |
Pharmaceuticals
Prescription, Generic, Biosimilar |
14.7B | 28.9% | 56.3% | 29.9% | - | -5.92% |
| ELAN Elanco Animal |
Pharmaceuticals
Parasiticides, Vaccines |
11.2B | 41.8% | - | 68.9% | 322 | 66.1% |
| RDY Dr. Reddy’s |
Pharmaceuticals
Generics, APIs, Biologics |
11.2B | 76.6% | 11.7% | -17.5% | 17.2 | -27.1% |
| IPN Ipsen |
Pharmaceuticals
Oncology, Rare Disease |
11.1B | 87.4% | 60.5% | 30.4% | 21.6 | -10.4% |
| JAZZ Jazz |
Pharmaceuticals
Sleep Disorder, Epilepsy, Oncology |
9.74B | 51.3% | - | 34.5% | - | 8.32% |
| AXSM Axsome Therapeutics |
Pharmaceuticals
Antidepressant, Anti-Sleepiness |
8.45B | 32.4% | - | 66.1% | - | 57.1% |
| AMRX Amneal |
Pharmaceuticals
Generics, Injectables |
4.15B | 64.7% | - | 73.3% | - | 39.0% |
| CORT Corcept |
Pharmaceuticals
Korlym, Relacorilant |
4.03B | 67.1% | - | -15.4% | 43.9 | -39.2% |
| TERN Terns |
Pharmaceuticals
Kinase Inhibitor, Thyroid Agonist |
3.86B | 34.5% | - | 54.4% | - | 512% |
| VIRP Virbac |
Pharmaceuticals
Vaccines, Antibiotics |
3.50B | 85.5% | 59.0% | 44.5% | 22.6 | -3.59% |
| TARS Tarsus |
Pharmaceuticals
Eye Therapy, Mite Blepharitis |
3.26B | 36.5% | - | 49.5% | - | 35.4% |
| PBH Prestige Brand |
Pharmaceuticals
Analgesic, Diaper, Throat, Eye |
3.16B | 63.5% | 1.0% | -32.1% | 15.9 | -28.8% |
| LQDA Liquidia |
Pharmaceuticals
Dry Powder Injectable Liposomal |
3.12B | 27.4% | - | 77.1% | - | 152% |
| SUPN Supernus |
Pharmaceuticals
ADHD, Epilepsy, Parkinson |
2.93B | 47.5% | - | 68.6% | - | 12.6% |
| BHC Bausch Health |
Pharmaceuticals
Gastroenterology, Dermatology |
2.75B | 51.3% | 3.14% | -17.0% | 7.64 | -17.1% |
| WVE Wave Life Sciences |
Pharmaceuticals
RNA Editing, GalNAc-Conjugated |
2.57B | 35.3% | - | -2.69% | - | 1.67% |
| OCUL Ocular Therapeutix |
Pharmaceuticals
Dexamethasone, Axitinib, Travoprost |
2.40B | 31.6% | - | 19.3% | - | 14.8% |
| HRMY Harmony |
Pharmaceuticals
Wakix, Pitolisant, BP1.15205 |
2.16B | 91.9% | - | 12.6% | 11.9 | -12.4% |
| AVDL Avadel |
Pharmaceuticals
Sodium Oxybate, Narcolepsy |
2.11B | 64.1% | - | 56.7% | - | 128% |
| DMP Dermapharm Holding |
Pharmaceuticals
Branded Generics, OTC |
2.11B | 75.0% | 30.2% | 5.64% | 16.9 | -18.7% |
| PRGO Perrigo |
Pharmaceuticals
OTC Medicines, Infant Nutrition |
2.08B | 46.3% | 70.0% | -54.5% | - | -45.8% |
| HROW Harrow Health |
Pharmaceuticals
Antibiotic, Steroid |
1.89B | 43.9% | - | 48.1% | - | 11.5% |
| OGN Organon |
Pharmaceuticals
Contraception, Fertility |
1.88B | 56.7% | 10.2% | -47.9% | 3.79 | -56.4% |
| MAZE Maze Therapeutics |
Pharmaceuticals
MZE829, MZE782, MZE001, Renal |
1.87B | 24.5% | - | 88.0% | - | 117% |
| ANIP ANI Pharmaceuticals |
Pharmaceuticals
Injectables, Softgels, Cortrophin |
1.71B | 69.0% | - | 38.9% | 47.7 | 17.1% |
| INVA Innoviva |
Pharmaceuticals
Inhaled Combo, Vasoconstrictor |
1.66B | 80.8% | 1.25% | 24.5% | 13.4 | -7.68% |
| PAHC Phibro Animal |
Pharmaceuticals
Antibacterials, Vaccines |
1.56B | 61.6% | 37.2% | 59.7% | 22.3 | 63.7% |
| ELVN Enliven |
Pharmaceuticals
Kinase Inhibitor, HER2 Inhibitor |
1.54B | 34.0% | - | 5.52% | - | -2.47% |
| EVT Evotec SE |
Pharmaceuticals
Oncology, Autoimmune, Metabolic |
1.48B | 22.2% | - | -49.8% | - | -35.4% |
| EYPT Eyepoint |
Pharmaceuticals
Sustained Drug Implant, VEGF |
1.45B | 29.0% | - | 68.2% | - | 73.4% |
| COLL Collegium |
Pharmaceuticals
Stimulant, Buccal, Opioid |
1.44B | 79.0% | - | 49.0% | 27.9 | 11.6% |
| TRVI Trevi Therapeutics |
Pharmaceuticals
Chronic Cough, Nalbuphine |
1.44B | 37.1% | - | 56.2% | - | 132% |
| RAPP Rapport |
Pharmaceuticals
Epilepsy, Neuropathic Pain |
1.38B | 32.7% | - | 65.3% | - | 71.6% |
| AMLX Amylyx |
Pharmaceuticals
Avexitide, AMX0035, AMX0114, GLP-1 |
1.34B | 30.2% | - | 25.7% | - | 218% |
| AMPH Amphastar P |
Pharmaceuticals
Injectable, Inhalation |
1.29B | 76.3% | - | -6.24% | 12.3 | -39.4% |
| SEPN Septerna, Common |
Pharmaceuticals
GPCR, Oral, Small-Molecule |
1.25B | 47.2% | - | 44.7% | - | 23.2% |
| XERS Xeris |
Pharmaceuticals
Glucagon, Cortisol, Paralysis |
1.20B | 63.7% | - | 46.9% | - | 100% |
| NBY NovaBay |
Pharmaceuticals
Wound Cleanser, Hypochlorous Acid |
1.19B | 51.6% | 34.4% | 37.3% | 1.83 | 3,057% |
| PHAT Phathom |
Pharmaceuticals
Tablet, Antibiotic, Proton-Pump |
1.11B | 66.3% | - | 54.4% | - | 87.8% |
| PCRX Pacira BioSciences |
Pharmaceuticals
EXPAREL, ZILRETTA, Iovera |
1.10B | 62.9% | - | -9.88% | 52.0 | -7.80% |
| TLRY Tilray |
Pharmaceuticals
Cannabis, Beverages, Wellness |
1.04B | 47.7% | - | -45.2% | - | -35.6% |
| CRON Cronos |
Pharmaceuticals
Dried Flower, Pre-Roll, Oil |
1.03B | 47.0% | - | 46.8% | 24.4 | 13.8% |
| TBPH Theravance |
Pharmaceuticals
COPD, Nebulizer, Norepinephrine |
964M | 51.0% | - | 84.0% | 33.4 | 83.9% |
| ARVN Arvinas |
Pharmaceuticals
Protac, Degrader, Breast |
894M | 39.9% | - | -2.09% | - | -44.5% |
| OMER Omeros |
Pharmaceuticals
Narsoplimab, OMS1029, Zaltenibart |
886M | 41.0% | - | 24.7% | - | 17.6% |
| CRMD CorMedix |
Pharmaceuticals
Antimicrobial, Catheter, Solution |
880M | 92.2% | - | -10.8% | 5.05 | -43.2% |
| NKTR Nektar Therapeutics |
Pharmaceuticals
Autoimmune, Inflammation, Cancer |
874M | 32.5% | - | 47.7% | - | 128% |
| AQST Aquestive |
Pharmaceuticals
Buccal Film, Sublingual Film, Oral |
758M | 59.4% | - | 7.11% | - | 4.09% |
| VTYX Ventyx Biosciences |
Pharmaceuticals
VTX958, Tamuzimod, VTX2735 |
717M | 35.3% | - | 63.4% | - | 486% |
| FULC Fulcrum |
Pharmaceuticals
Pociredir, Losmapimod, Fetal |
667M | 23.1% | - | 23.7% | - | 95.6% |
| ANRO Alto Neuroscience |
Pharmaceuticals
Antidepressant, Cognitive |
514M | 31.7% | - | 51.3% | - | 219% |
| BIOA BioAge Labs |
Pharmaceuticals
Azelaprag, BGE-102, Obesity |
503M | 34.7% | - | 65.7% | 1.03 | 147% |
| SIGA SIGA Technologies |
Pharmaceuticals
Antiviral, Smallpox Treatment |
473M | 79.6% | 80.1% | 20.8% | 6.42 | -0.27% |
| CGC Canopy Growth |
Pharmaceuticals
Dried Flower, Extracts, Edibles |
465M | 17.5% | - | -41.6% | - | -57.4% |
| ETON Eton |
Pharmaceuticals
Adrenal, Wilson, PKU, Tyrosinemia |
443M | 57.1% | - | 12.9% | - | -8.57% |
| SNDL SNDL |
Pharmaceuticals
Cannabis, Alcohol, Retail, Flower |
422M | 50.9% | - | -45.6% | - | -23.7% |
| EOLS Evolus |
Pharmaceuticals
Botulinum Toxin, Hyaluronic Acid |
366M | 28.9% | - | -63.4% | - | -52.3% |
| CTNM Contineum |
Pharmaceuticals
PIPE-791, PIPE-307, CTX-343 |
340M | 30.5% | - | -35.3% | - | -41.7% |
| RLMD Relmada |
Pharmaceuticals
Gemcitabine, Docetaxel |
331M | 45.2% | - | 73.0% | - | 783% |
| AARD Aardvark |
Pharmaceuticals
ARD-101, ARD-201, Small-Molecule |
316M | 25.5% | - | -2.86% | - | -13.4% |
| ACRS Aclaris |
Pharmaceuticals
JAK Inhibitor, TSLP Antibody |
286M | 32.8% | - | -13.1% | - | -11.9% |
| NMRA Neumora |
Pharmaceuticals
Depression, Agitation, Alzheimer |
282M | 49.5% | - | -17.9% | - | -24.1% |
| AVIR Atea |
Pharmaceuticals
Antiviral, Oral, Hepatitis |
270M | 30.4% | - | -5.06% | - | -10.7% |
| ACB Aurora Cannabis |
Pharmaceuticals
Cannabis, Oils, Capsules, Edibles |
239M | 67.2% | - | -47.8% | - | -13.1% |
| ALTS ALT5 Sigma |
Pharmaceuticals
Trading Platform, Payment Gateway |
239M | 26.4% | 1.0% | -51.0% | - | -76.6% |
| MDWD Mediwound |
Pharmaceuticals
Burn Debridement, Chronic Wound |
237M | 20.2% | - | 20.3% | - | -15.4% |
| OGI OrganiGram Holdings |
Pharmaceuticals
Cannabis, Flower, Pre-Rolls |
226M | 20.8% | - | 1.44% | - | -9.30% |
| MIST Milestone |
Pharmaceuticals
Etripamil, Calcium Channel |
187M | 24.5% | - | -11.3% | - | -14.3% |
| CNTX Context |
Pharmaceuticals
Anti-Claudin6 Bispecific, T-Cell |
148M | 29.8% | - | 63.1% | - | 29.4% |
| SAVA Cassava Sciences |
Pharmaceuticals
Simufilam, SavaDx |
142M | 34.6% | 1.0% | -48.5% | - | -36.3% |
| IRD Opus Genetics |
Pharmaceuticals
Gene Therapy, Retinal Diseases |
138M | 40.0% | - | 21.6% | - | 32.1% |
| ELTX Elicio Therapeutics |
Pharmaceuticals
Vaccine, Lymph Node, Preclinical |
136M | 45.7% | - | -5.49% | - | 13.9% |
| VRCA Verrica |
Pharmaceuticals
Cantharidin, VP-102, VP-315 |
127M | 26.1% | - | 3.87% | - | 3.59% |
| SLGL Sol Gel |
Pharmaceuticals
Acne Cream, Rosacea Cream, Gorlin |
99.1M | 28.6% | - | 60.8% | - | 290% |
| SCLX Scilex Holding |
Pharmaceuticals
Lidocaine, Migraine, Anti-Gout |
92.1M | 67.5% | - | -50.9% | - | -31.7% |
| CPIX Cumberland |
Pharmaceuticals
Injection, Acetaminophen, Pain |
59.8M | 49.4% | - | 60.0% | - | 75.9% |
| LPCN Lipocine |
Pharmaceuticals
Testosterone, Oral, CNS, Prodrug |
41.8M | 27.1% | - | 24.8% | - | 44.5% |
| EVOK Evoke Pharma |
Pharmaceuticals
Nasal Spray, Diabetic Gastroparesis |
19.0M | 30.9% | - | 48.6% | - | 341% |
| ASBP Aspire BioPharma |
Pharmaceuticals
Sublingual Tablets, Aspirin |
14.4M | 39.1% | - | -80.9% | - | -99.2% |
| KALA Kala |
Pharmaceuticals
KPI-012, KPI-014, Eye Therapy |
14.3M | 25.4% | - | -61.7% | - | -92.0% |
| YCBD cbdMD |
Pharmaceuticals
CBD Tinctures, Gummies, Topicals |
6.58M | 15.4% | - | -49.2% | 1.45 | -77.3% |